MTOR and urinary bladder cancer: The phosphoinositide 3 kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) pathway is crucial, as it regulates cell growth, proliferation, and survival, and its de-regulation has been reported in 40% of bladder cancers [12].